Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation

NCT04798898 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT04798898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04798898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Recruiting
Start date
November 14, 2022
Completion date
December 1, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver metastasis colon cancer